Search for: "USA v. ANDREWS"
Results 21 - 40
of 493
Sorted by Relevance
|
Sort by Date
4 Aug 2010, 12:50 pm
Oral Argument in case# 10-1022; USA v. [read post]
21 Jan 2011, 1:22 pm
Oral Argument in case# 09-3025; Andrew Koons v. [read post]
2 Jun 2014, 7:48 am
Fresenius Kabi USA, LLC v. [read post]
31 Jul 2012, 2:08 pm
USA, Inc. v. [read post]
9 Oct 2014, 9:59 pm
By Andrew Williams -- Next week, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. [read post]
31 Mar 2014, 8:47 pm
By Andrew Williams -- Earlier today, the Supreme Court granted certiorari in the Teva Pharmaceuticals USA, Inc. v. [read post]
25 Jun 2015, 9:48 pm
By Andrew Williams -- On June 18, 2015, the Federal Circuit handed down its second opinion in the Teva Pharmaceuticals USA v. [read post]
6 Mar 2021, 2:18 pm
By Memorandum Opinion entered in Conformis, Inc. v. [read post]
16 Jan 2021, 8:38 am
By Memorandum Opinion entered in Allergan USA, Inc. et al. v. [read post]
18 Apr 2017, 1:37 pm
Satander Consumer USA Inc., No. 16-349. [read post]
10 Feb 2017, 10:52 am
Andrews in Endo Pharmaceuticals Inc. et al. v. [read post]
7 Feb 2014, 12:22 pm
Judge Andrews found this inquiry to accord with the reasoning from Uniloc USA, Inc. v. [read post]
29 Oct 2013, 2:32 pm
(USA) Inc., et al., C.A. [read post]
9 Dec 2010, 6:32 am
Supreme Court’s decision in Connick v. [read post]
19 Jul 2022, 7:46 am
., Ltd. and HEC Pharm USA Inc., vacated its prior decision, and reversed the district court’s judgment that the claims of patent at issue were not invalid (Novartis Pharmaceuticals Corporation. v. [read post]
6 Feb 2014, 9:59 pm
By Andrew Williams -- The standard of review at the Federal Circuit is important. [read post]
15 May 2018, 9:19 pm
By Andrew Williams -- Since the Supreme Court's decision in TC Heartland LLC v. [read post]
3 Aug 2011, 2:10 pm
By Andrew Wooley The Supreme Court of Texas’ recent decision in Marsh USA Inc. v. [read post]
21 Nov 2012, 11:32 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
17 May 2009, 9:55 pm
By Andrew Williams -- Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix ®. [read post]
